about
Steady-state pharmacokinetics and bioavailability of immediate-release and extended-release formulations of lamotrigine in elderly epilepsy patients: Use of stable isotope methodologyOne ring to dissolve them all.Safety and tolerability of adjunctive brivaracetam as intravenous infusion or bolus in patients with epilepsy.
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Safety of an intravenous formulation of lamotrigine
@ast
Safety of an intravenous formulation of lamotrigine
@en
type
label
Safety of an intravenous formulation of lamotrigine
@ast
Safety of an intravenous formulation of lamotrigine
@en
prefLabel
Safety of an intravenous formulation of lamotrigine
@ast
Safety of an intravenous formulation of lamotrigine
@en
P2093
P2860
P1476
Safety of an intravenous formulation of lamotrigine
@en
P2093
Angela K Birnbaum
Ilo E Leppik
James R White
Jeannine M Conway
John O Rarick
Page B Pennell
Rory P Remmel
P2860
P304
P356
10.1016/J.SEIZURE.2014.01.019
P577
2014-01-31T00:00:00Z